Concert Pharmaceuticals, Inc. Operating Lease Liability
Concert Pharmaceuticals, Inc. had Operating Lease Liability of $15.06 million as of 2021-12-31, per its 10-K filed 2022-03-03.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2022-11-07
- 2021-12-31: Operating Lease, Liability $15.06M.
- 2020-12-31: Operating Lease, Liability $16.00M.
- 2019-12-31: Operating Lease, Liability $16.26M.
- 2019-09-30: Operating Lease, Liability $16.43M.
| Period end | Operating Lease, Liability |
|---|---|
| 2021-12-31 | $15.06M 10-K · filed 2022-03-03 |
| 2020-12-31 | $16.00M 10-K · filed 2021-02-25 |
| 2019-12-31 | $16.26M 10-K · filed 2020-02-27 |
| 2019-09-30 | $16.43M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $16.58M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $16.73M 10-Q · filed 2019-05-02 |
| 2019-01-01 | $16.90M 10-Q · filed 2022-11-07 |
| 2018-12-31 | $16.73M 10-Q · filed 2019-05-02 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-07 |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-01 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-02 |